Health In Tech, Inc. faces Nasdaq delisting risks
- Received Nasdaq notice for non-compliance with independent director rules
- Class A stock bid price below $1.00 for 30 days
- Cure period until April 12, 2027 for bid price rule
Every EDGAR filing for Health In Tech, Inc. (HIT), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 12 ยท 10-Q expected ~Nov 12 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Also: 2 grants or exercises.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
William D. Howard, insider filing for HIT
William D. Howard, reporting
Ownership stake disclosure by Laurence W Lytton
Laurence W Lytton, filed by
Zain Syed Hasan, insider filing for HIT
Zain Syed Hasan, reporting
Timothy Hayes, insider filing for HIT
Timothy Hayes, reporting
Timothy Hayes, planned sale of HIT shares
Timothy Hayes, reporting
Timothy Hayes, planned sale of HIT shares
Timothy Hayes, reporting
Zain Syed Hasan, insider filing for HIT
Zain Syed Hasan, reporting
Timothy Hayes, insider filing for HIT
Timothy Hayes, reporting
Zain Syed Hasan, planned sale of HIT shares
Zain Syed Hasan, reporting
LinLin Qian, insider filing for HIT
LinLin Qian, reporting
Zain Syed Hasan, insider filing for HIT
Zain Syed Hasan, reporting
Sanjay K Shrestha, insider filing for HIT
Sanjay K Shrestha, reporting
Zain Syed Hasan, insider filing for HIT
Zain Syed Hasan, reporting
Jonathan Del Lockett, insider filing for HIT
Jonathan Del Lockett, reporting
LinLin Qian, insider filing for HIT
LinLin Qian, reporting